These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10602926)

  • 1. SonoVue, a new ultrasound contrast agent.
    Schneider M
    Eur Radiol; 1999; 9 Suppl 3():S347-8. PubMed ID: 10602926
    [No Abstract]   [Full Text] [Related]  

  • 2. SonoVue in transcranial Doppler investigations of the cerebral arteries.
    Kaps M; Legemate DA; Ries F; Ackerstaff RG; Markus H; Pezzoll C; Llull JB; Spinazzi A
    J Neuroimaging; 2001 Jul; 11(3):261-7. PubMed ID: 11462292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcranial duplex imaging with a sulfurhexafluoride echocontrast agent: enhancement and diagnostic quality.
    Schweikert K; Operschall C; Llull JB; Lyrer P
    J Neuroimaging; 2002 Jan; 12(1):19-27. PubMed ID: 11826593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of echocontrast agent infusion in a dog model.
    Kaps M; Seidel G; Algermissen C; Gerriets T; Broillet A
    J Neuroimaging; 2001 Jul; 11(3):298-302. PubMed ID: 11462298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and ultrasound-enhancing potentials of a new sulfur hexafluoride-containing agent in the cerebral circulation.
    Kaps M; Seidel G; Bokor D; Modrau B; Algermissen C
    J Neuroimaging; 1999 Jul; 9(3):150-4. PubMed ID: 10436756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging.
    Morel DR; Schwieger I; Hohn L; Terrettaz J; Llull JB; Cornioley YA; Schneider M
    Invest Radiol; 2000 Jan; 35(1):80-5. PubMed ID: 10639039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced transcranial color-coded sonography in acute cerebral infarction.
    Cheung RT
    Stroke; 2000 Aug; 31(8):2025-6. PubMed ID: 10926974
    [No Abstract]   [Full Text] [Related]  

  • 8. [Contrast media in ultrasonography: from synthesis to clinical use. The Sonovue example].
    Schneider M
    Ann Cardiol Angeiol (Paris); 2002 Sep; 51(4):218-20. PubMed ID: 12471806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new Doppler signal enhancing agent for flow assessment in breast lesions.
    Madjar H; Prömpeler HJ; Del Favero C; Hackelöer BJ; Llull JB
    Eur J Ultrasound; 2000 Dec; 12(2):123-30. PubMed ID: 11118919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudo-left ventricle apical hypertrophy: bedside diagnosis with SonoVue contrast.
    Comella A; Magnacca M
    Echocardiography; 2004 Aug; 21(6):563-4. PubMed ID: 15298696
    [No Abstract]   [Full Text] [Related]  

  • 11. Doppler intensitometry with BR1, a sonographic contrast agent.
    Schneider M; Broillet A; Arditi M; Ventrone R; Puginier J
    Acad Radiol; 1996 Aug; 3 Suppl 2():S308-11. PubMed ID: 8796588
    [No Abstract]   [Full Text] [Related]  

  • 12. Ultrasound imaging with SonoVue: low mechanical index real-time imaging.
    Bauer A; Solbiati L; Weissman N
    Acad Radiol; 2002 Aug; 9 Suppl 2():S282-4. PubMed ID: 12188249
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic efficacy of SonoVue.
    Bokor D
    Am J Cardiol; 2000 Aug; 86(4A):19G-24G. PubMed ID: 10997347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with SonoVue in myocardial perfusion imaging.
    Rovai D; Morales MA; Amyot R; L'Abbate A
    Echocardiography; 2000 Aug; 17(6 Pt 2):S17-23. PubMed ID: 11058235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infusion versus bolus of an ultrasound contrast agent: in vivo dose-response measurements of BR1.
    Correas JM; Burns PN; Lai X; Qi X
    Invest Radiol; 2000 Jan; 35(1):72-9. PubMed ID: 10639038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit of echocontrast-enhanced transcranial arterial color-coded duplex ultrasound.
    Droste DW; Boehm T; Ritter MA; Dittrich R; Ringelstein EB
    Cerebrovasc Dis; 2005; 20(5):332-6. PubMed ID: 16131802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of myocardial perfusion by intermittent harmonic power Doppler using SonoVue, a new ultrasound contrast agent.
    Broillet A; Puginier J; Ventrone R; Schneider M
    Invest Radiol; 1998 Apr; 33(4):209-15. PubMed ID: 9556745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous perfluoropropane-exposed sonicated dextrose albumin produces myocardial ultrasound contrast that correlates with coronary blood flow.
    Porter TR; Xie F; Kilzer K
    J Am Soc Echocardiogr; 1995; 8(5 Pt 1):710-8. PubMed ID: 9417215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of repetitive contrast agent injections on functional and molecular ultrasound measurements.
    Rix A; Palmowski M; Gremse F; Palmowski K; Lederle W; Kiessling F; Bzyl J
    Ultrasound Med Biol; 2014 Oct; 40(10):2468-75. PubMed ID: 25023096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of contrast-enhanced ultrasound in large vessels.
    Martegani A; Aiani L; Borghi C
    Eur Radiol; 2004 Oct; 14 Suppl 8():P73-86. PubMed ID: 15700335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.